Viewing Study NCT00996593

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 1:02 AM
Ignite Modification Date: 2025-12-29 @ 8:51 PM
Study NCT ID: NCT00996593
Status: COMPLETED
Last Update Posted: 2016-11-23
First Post: 2009-10-08
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Study of Iodine-131 Anti-B1 Antibody for Patients With Non Hodgkin's Lymphoma Who Have Previously Received Rituximab
Sponsor: GlaxoSmithKline
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Lymphoma, Non-Hodgkin View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Tositumomab View
None radioimmunotherapy View
None rituximab View
None anti-B1 View
None I 131 View
None Bexxar View
None iodine View
None non-Hodgkin's lymphoma View